About

About
The DS management team has both a strong background in developing drugs for the market and experience in building life science companies.

Pipeline

Pipeline
DS Biopharma have three novel assets in various stages of clinical and pre-clinical development and intend to add more bioactive lipids to the current portfolio in the coming years.

Investors

Investors
To date, DS Biopharma have been funded privately.

Latest News

June 15, 2015

DS Biopharma announces receipt of two Notices of Allowance for U.S. patent applications covering the manufacture and methods of use for its bioactive compounds

Dublin, Ireland, June 15, 2015 – DS Biopharma (DS), a privately held drug discovery and development company, announced today that the United States Patent and Trademark […]
May 15, 2015

DS Biopharma making waves in lipids

Article featured in The Pharma Letter Making waves in lipids: DS Biopharma DS Biopharma is an Ireland-based biopharma drug discovery company aiming to tackle unmet medical […]

Join our mailing list

Connect with us